Professional Documents
Culture Documents
INTRODUCTION
(Leigh Hunt)
Initial therapy for ACS should focus on stabilizing the patient's condition,
relieving ischemic pain, and providing antithrombotic therapy to reduce myocardial
1
damage and prevent further ischemia. Morphine (or fentanyl) for pain control,
oxygen, sublingual or intravenous (IV) nitroglycerin, soluble aspirin 162-325 mg, and
clopidogrel with a 300- to 600-mg loading dose are given as initial treatment. High-
risk patients with non-ST-segment elevation myocardial infarction (NSTEMI ACS)
should receive aggressive care, including aspirin, clopidogrel, unfractionated heparin
or low–molecular-weight heparin (LMWH), IV platelet glycoprotein IIb/IIIa complex
blockers (eg, tirofiban, eptifibatide), and a beta blocker. The therapeutic and surgical
treatment is PTCA (Percutaneous Transluminal Coronary Angioplasty) and CABG
(Coronary Artery Bypass Grafting). 5
Medical and pharmacological treatments cause many side effects like Nitrates
cause severe headache, Hypotension, Aspirin cause severe nausea, vomiting, stomach
pain, bloody of tarry stool, hemoptysis, fever etc. Surgical treatments are also having
some disadvantages or risks like the coronary artery may be torn or ruptured
(dissected) during the angioplasty and CABG has a higher risk of mortality nearly 3-
4% and also there is a risk for Chest infections and pulmonary complications.6
Buerger Allen exercise refers an active postural exercise, which help in fills
and empties the lower extremity blood vessels according to gravity alternatives refers
a three steps (elevation, dependency, horizontal).7
The term acute coronary syndrome refers to any group of clinical symptoms
compatible with acute myocardial ischemia and includes unstable angina, non—ST-
segment elevation myocardial infarction, and ST-segment elevation myocardial
infarction. It is characterized by Chest Pain radiating to arms, neck and jaw, Shortness
of breath, nausea and sweating. The lower limb tissue perfusion causes Altered mental
status, Altered sensations, Altered skin characteristics (Cold extremities, blue or
purple skin color), Weak or absent pulse etc. Risk factors for ACS include older age,
previous atheromatous cardiovascular disease, diabetes, smoking, hypertension,
hypercholesterolemia, male sex, and a family history of premature ischemic heart
disease. ACS may also occur alongside valvular disease, arrhythmias, and
cardiomyopathies.8
2
In the United States, an ACS occurs every 25 seconds, and an ACS-related
death occurs in every 2 minute. Each year in this country, approximately 1.4 million
patients are hospitalized for ACS, of which 810,000 are for myocardial infarction
(MI). Also, about three-quarters of deaths from MI are caused by plaque rupture. The
remaining 25% are caused by superficial endothelial erosion.3 The proportion of ACS
with STEMI—when a blood clot completely blocks a coronary artery—is
declining,1possibly due to reductions in smoking, aging of the population (STEMI is
more common in middle age, while NSTEMI occurs more in the elderly), and greater
use of statin therapy. Similar trends have been seen for sudden cardiac arrest.
NSTEMI—usually when a clot partially blocks a coronary artery—is now the
dominant type of ACS, and outcomes after the acute phase are significantly worse
than for STEMI.9
India has the highest burden of ACS in the world. The CREATE registry has
provided contemporary data on 20,468 patients from 89 centers from 10 regions and
50 cities in India.The three most common risk factors for ACS were smoking (40%),
high blood pressure (38%), and diabetes (30%). The prevalence of dyslipidemia
(cholesterol abnormalities) was unfortunately not available or reported. 59% of
patients with STEMI received thrombolytics (96% streptokinase). Coronary
angioplasty was given to 8% of STEMI and 7% of non-STEMI; coronary bypass
surgery was given to 2% of STEMI and 4% of NSTEMI/UA. The 30-day outcomes
for patients with STEMI were: death 9%; reinfarction 2%; and stroke 0.7%. Poor
patients were less likely to get evidence-based treatments, and had greater 30-day
mortality than wealthy patients (8% vs 6% p<0.0001). Adjustment for treatments (but
not risk factors and baseline characteristics) eliminated this difference in mortality.
98% received anti-platelet drugs; 51%-61% received angiotensin-converting enzyme
(ACE) inhibitors or angiotensin receptor blockers (ARB) and 51-54% received lipid-
lowering therapy.10
Buerger-Allen exercise is a specific exercise intended to improve circulation
to the feet and legs. The lower extremities are elevated to a 45 to 90 degree angle and
supported in this position until the skin blanches (appears dead white). The feet and
legs are then lowered below the level of the rest of the body until redness appears
(care should be taken that there is no pressure against the back of the knees); finally,
the legs are placed flat on the bed for a few minutes. The length of time for each
3
position varies with the patient's tolerance and the speed with which color change
occurs. Usually the exercises are prescribed so that the legs are elevated for 2 to 3
minutes, down 5 to 10 minutes and then flat on the bed for 10 minutes. 11
REVIEW OF LITERATURE
4
incidence of CHD in the province of Quebec, and to determine the proportion of CHD
mortality that had no previous CHD diagnosis. METHODS: Trends in prevalence,
incidence and mortality were examined with a population-based study using the
Quebec Integrated Chronic Disease Surveillance System, which links several health
administrative databases. Data are presented using two case definitions for Quebecers
aged 20 years and over: 1) a validated definition, and 2) CHD causes of death codes
added to estimate the proportion of deaths that occurred without any previous CHD
diagnosis as a proxy for sudden cardiac death (SCD). RESULTS: In 2012/2013, the
crude prevalence of CHD was 9.4%, Between 2000/2001 and 2012/2013, the age-
standardized prevalence increased by 14%, Age-standardized incidence and mortality
rates decreased by 46% and 26% respectively, and represented a crude rate of 6.9 per
1000 and 5.2% in 2012/2013. CONCLUSION: The prevalence of CHD has tended to
decrease in recent years, and incidence and mortality have been declining in
Quebec.14
5
refill (2-3sec) and post test capillary refill (1-2sec) and extremity pulses increased
10%in 50%of total population .the overall benefit seen in 7 patients after 24 hours
evidenced by (increased perfusion and activity). The study concluded that buerger
allen exercise is effective for improving lower extremity perfusion.16
6
OBJECTIVES OF THE STUDY
1. To assess the level of lower limb tissue perfusion among the patients with
acute coronary syndrome.
2. To assess the effectiveness of Buerger Allen exercise on lower limb tissue
perfusion among patients with acute coronary syndrome.
3. To find the association between the level of lower limb tissue perfusion among
the patients with acute coronary syndrome with their selected Demographic
variables.
RESEARCH HYPOTHESIS
H2- There will be significance association between level of lower limb tissue
perfusion with selected demographic variables among patients with acute coronary
syndrome.
OPERATIONAL DEFINITIONS
7
and unstable angina that are caused by the same underlying problem. The
underlying problem is a sudden reduction of blood flow to part of the heart
muscle.
ASSUMPTIONS
1. The patients with acute coronary syndrome will be having problem with lower
limb tissue perfusion.
2. Practice of Buerger Allen exercise will help to improve lower limb tissue perfusion
in patients with acute coronary syndrome.
DELIMITATIONS
1. Study will help to identify the level of practice for buerger allen exercise.
2. The study will help the patients with acute coronary syndrome to better
understand about effectiveness of buerger allen exercise on improving
lower limb tissue perfusion.
SOURCE OF DATA
The data will be collected from the patients with acute coronary syndrome
admitted in the selected hospital of Rajkot who are above 20 years.
8
PLAN FOR DATA COLLECTION
The investigator would get the permission prior to data collection from
concerned authority. The investigator will introduce him to the participants.
Assessment of the lower limb tissue perfusion by using observation checklist and data
will be collected from them using baseline data. Nature and purpose of the study and
about practice of buerger allen exercise will be explained and obtain consent from
them. Buerger’s Allen exercise will be administered on same day (duration- 12
minutes, frequency-4, and interval-3hous) among experimental group. The tissue
perfusion levels will the measured by the Enhanced Foot Assessment scale after 7
days. Post test assessment of lower limb tissue perfusion will be after practicing the
buerger allen exercise.
RESEARCH DESIGN
SAMPLING PROCEDURE
POPULATION
9
ACCESSIBLE POPULATION:
Patients admitted with reduced lower limb tissue perfusion with acute coronary
syndrome.
SAMPLING CRITERIA
SAMPLING TECHNIQUE
SAMPLE SIZE
SETTING
PILOT SUDY
VARIABLES
10
DATA ANALYSIS PLAN
DESCRIPTIVE STATISTICS
INFERENTIAL STATISTICS
1. Paired “t” test will be used to assess the effectiveness of buerger allen exercise
on improving lower limb tissue perfusion.
2. Chi-square test will be used to associate level of lower limb tissue perfusion
among patients with their selective demographic variables.
ETHICAL CLEARANCE
Yes.
Yes.
The study will be conducted after the approval of research committee in the
college. The nature and purpose of the study will be explained to the
participants. The written consent will be obtained from participants to gain full
co-operation. Assurance will be given to the study samples that the anonymity
of each individual would be maintained strictly.
11
LIST OF PREFERENCES
6. Thandani U, Repley TL; Side effects of drugs to treat heart failure and the acute
coronary syndromes, unstable angina and acute myocardial infarction (online),
Available from: https://www.ncbi.nlm.nih.gov (Accessed on 10 April 2017)
8. Brunner & Suddarth; Text book of Medical-Surgical Nursing, 10th Edition, 2008,
725-750
10. Dr. Enas; Acute coronary syndrome in India (online). Available from:
http://www.cadiresearch.org (Accessed on 11 April 2017)
11. Dr. Prodyut Das (PT); Buerger Allen exercise (online). Available from:
http://www.physiotherapy-treatment.com (Accessed on 20 March 2017)
12
12. Grover A., Kamins M. A., Martin I. M., Davis S., Haws K., Mirabito A. M.,
Mukherjee S., Pirouz D., Rapp J. From use to abuse: When everyday consumption
behaviors morph into addictive consumptive behaviors. Journal of Research for
Consumers. 2011; 19:1–8.
15. Chang-Cheng Chang, Men-Yen Chen, Jen-Hsiang Shen, Yen Bin Lin, MD, Wen-
Wei Hsu and Bor-shyh Lin; A quantitative real-time assessment of Buerger exercise
on dorsal foot peripheral skin circulation in patients with diabetes foot (online).
Available from: https://www.ncbi.nlm.nih.gov (Accessed on 10 April 2017)
16. Leonard Syme; The prevention of disease and promotion of health:the need for a
new approach,: European Journal of Public Health; 2015 :329-330.
13